Protagonist Therapeutics, Inc. (NASDAQ:PTGX) Receives Average Recommendation of “Buy” from Analysts
Shares of Protagonist Therapeutics, Inc. (NASDAQ:PTGX – Get Free Report) have been assigned a consensus recommendation of “Buy” from the nine brokerages that are currently covering the company, Marketbeat reports. One investment analyst has rated the stock with a hold rating, seven have given a buy rating and one has assigned a strong buy rating […]
28 Dec 04:40 · The Cerbat Gem